Free Trial

Johnson & Johnson: FT Article On Class Action Litigation Finance

HEALTHCARE

Johnson & Johnson (JNJ: Aaa/AAA neg)

The FT give a good summary of the growth in Litigation Finance driven by Private Equity backers and its impact on the risk for large corporations.

JNJ's latest class action lawsuit may see the company paying $6.5bn in present value to resolve 10s of thousands of claims alleging cancer caused by its talc products.

Keep reading...Show less
61 words

To read the full story

Close

Why MNI

MNI is the leading provider

of intelligence and analysis on the Global Fixed Income, Foreign Exchange and Energy markets. We use an innovative combination of real-time analysis, deep fundamental research and journalism to provide unique and actionable insights for traders and investors. Our "All signal, no noise" approach drives an intelligence service that is succinct and timely, which is highly regarded by our time constrained client base.

Our Head Office is in London with offices in Chicago, Washington and Beijing, as well as an on the ground presence in other major financial centres across the world.

Johnson & Johnson (JNJ: Aaa/AAA neg)

The FT give a good summary of the growth in Litigation Finance driven by Private Equity backers and its impact on the risk for large corporations.

JNJ's latest class action lawsuit may see the company paying $6.5bn in present value to resolve 10s of thousands of claims alleging cancer caused by its talc products.

Keep reading...Show less